These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 2762434)

  • 1. Diagnosing major depression in cocaine abusers: the use of depression rating scales.
    Weiss RD; Griffin ML; Mirin SM
    Psychiatry Res; 1989 Jun; 28(3):335-43. PubMed ID: 2762434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting depressive disorders in drug abusers: a comparison of screening instruments.
    Rounsaville BJ; Weissman MM; Rosenberger PH; Wilber CH; Kleber HD
    J Affect Disord; 1979 Dec; 1(4):255-67. PubMed ID: 162487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the best screening test for depression in chronic spinal pain patients?
    Choi Y; Mayer TG; Williams MJ; Gatchel RJ
    Spine J; 2014 Jul; 14(7):1175-82. PubMed ID: 24225008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing depression in substance abusers: Beck Depression Inventory and SCL-90R.
    Moffett LA; Radenhausen RA
    Addict Behav; 1990; 15(2):179-81. PubMed ID: 2343793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of male and female cocaine abusers.
    Griffin ML; Weiss RD; Mirin SM; Lange U
    Arch Gen Psychiatry; 1989 Feb; 46(2):122-6. PubMed ID: 2913971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the BDI-II and the PHQ-9 with outpatient substance abusers.
    Dum M; Pickren J; Sobell LC; Sobell MB
    Addict Behav; 2008 Feb; 33(2):381-7. PubMed ID: 17964079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute dually diagnosed inpatients: the use of self-report symptom severity instruments in persons with depressive disorders and cocaine dependence.
    Kush FR; Sowers W
    J Subst Abuse Treat; 1997; 14(1):61-6. PubMed ID: 9218238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).
    de Oliveira GN; Lessa JM; Gonçalves AP; Portela EJ; Sander JW; Teixeira AL
    Epilepsy Behav; 2014 May; 34():50-4. PubMed ID: 24681386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for anxiety and depression in dialysis patients: comparison of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory.
    Preljevic VT; Østhus TB; Sandvik L; Opjordsmoen S; Nordhus IH; Os I; Dammen T
    J Psychosom Res; 2012 Aug; 73(2):139-44. PubMed ID: 22789418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of depression: a comparison of rating scales.
    Faravelli C; Albanesi G; Poli E
    J Affect Disord; 1986; 11(3):245-53. PubMed ID: 2951412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor structure and diagnostic efficiency of the BDI-II in treatment-seeking substance users.
    Seignourel PJ; Green C; Schmitz JM
    Drug Alcohol Depend; 2008 Mar; 93(3):271-8. PubMed ID: 18093749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the psychometric properties of the Beck Depression Inventory-II, the Montgomery and Åsberg Depression Rating Scale, and the Hospital Anxiety and Depression Scale in a sample from a healthy population.
    Kjaergaard M; Arfwedson Wang CE; Waterloo K; Jorde R
    Scand J Psychol; 2014 Feb; 55(1):83-9. PubMed ID: 24256317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of self-rating scales for screening of depression in coronary artery disease patients.
    Bunevicius A; Staniute M; Brozaitiene J; Bunevicius R
    J Psychosom Res; 2012 Jan; 72(1):22-5. PubMed ID: 22200518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of depression: comparison between Beck Depression Inventory and subscales of Comprehensive Psychopathological Rating Scale.
    Martinsen EW; Friis S; Hoffart A
    Acta Psychiatr Scand; 1995 Dec; 92(6):460-3. PubMed ID: 8837974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of two depressive symptomatology measures in residential substance abuse treatment clients.
    Hepner KA; Hunter SB; Edelen MO; Zhou AJ; Watkins K
    J Subst Abuse Treat; 2009 Oct; 37(3):318-25. PubMed ID: 19359127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaine abuse among schizophrenic patients.
    Brady K; Anton R; Ballenger JC; Lydiard RB; Adinoff B; Selander J
    Am J Psychiatry; 1990 Sep; 147(9):1164-7. PubMed ID: 2386250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploratory Factor Analysis of the Beck Anxiety Inventory and the Beck Depression Inventory-II in a Psychiatric Outpatient Population.
    Lee K; Kim D; Cho Y
    J Korean Med Sci; 2018 Apr; 33(16):e128. PubMed ID: 29651821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy.
    de Lemos Zingano B; Guarnieri R; Diaz AP; Schwarzbold ML; Bicalho MA; Claudino LS; Markowitsch HJ; Wolf P; Lin K; Walz R
    Epilepsy Behav; 2015 Sep; 50():61-6. PubMed ID: 26119622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presentation and validation of the multiple sclerosis depression rating scale: a test specifically devised to investigate affective disorders in multiple sclerosis patients.
    Quaranta D; Marra C; Zinno M; Patanella AK; Messina MJ; Piccininni C; Batocchi AP; Gainotti G
    Clin Neuropsychol; 2012; 26(4):571-87. PubMed ID: 22428778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.